NeuroMetrix, Inc. NURO · Stock Open NeuroMetrix, Inc. in new tab
NeuroMetrix, Inc. Analysis (NURO)
Is NeuroMetrix, Inc. a good investment? NeuroMetrix, Inc. (NURO) is currently trading at 4.58 USD.
Investor FAQ
Does NeuroMetrix, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is NeuroMetrix, Inc.?
NeuroMetrix, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing and sale of medical devices. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; and Quell, a wearable device for symptomatic relief and management of chronic pain. The company offers its products to managed endocrinologists, podiatrists, primary care physicians, and other clinicians at the point-of care to objectively detect, stage, and monitor peripheral neuropathies. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
| Year | Total Dividends |
|---|---|
| ▸2007 |
0.15 USD
|
| April 13, 2007 | 0.1500 |
| Split Date | Split Ratio to 1 |
|---|---|
| Sept. 2, 2011 | 0.17 |
| Feb. 19, 2013 | 0.17 |
| Dec. 2, 2015 | 1:4 |
| May 12, 2017 | 0.12 |
| Nov. 19, 2019 | 1:10 |
| Nov. 22, 2023 | 0.12 |
Community Discussion